Dissection of the expressed actionable fusions’ repertoire in solid tumors tested serially in the clinical setting across 14 cancer types | NeoGenomics Laboratories

Publication date

Sun, 06/05/2022 - 12:00

Year

Subtitle

ASCO 2022

External link

https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.e18804

Division